» Articles » PMID: 1731329

Methotrexate Induces Differentiation of Human Keratinocytes

Overview
Specialty Science
Date 1992 Jan 15
PMID 1731329
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Terminal differentiation is a key element in the maintenance of tissue homeostasis in the epidermis. We show here that methotrexate (MTX) induces differentiation of human epidermal keratinocytes in vitro. MTX inhibits proliferation of keratinocytes and also induces several markers of differentiation: a change in cell morphology, a marked increase in cell size, an increase in the proportion of cells that express involucrin, and an increase in the amount of cornified envelope protein. These effects of MTX are dose- and exposure-time-dependent and become irreversible after 24 hr, approximately one population doubling time. These effects of MTX cannot be attributed to cytotoxicity since keratinocytes not only remain viable but also actively synthesize proteins. MTX causes reproducible changes in the SDS/PAGE profiles of newly synthesized proteins and, in particular, increases the amount of involucrin synthesis. Thymidine completely prevents these effects of MTX, suggesting that they are caused by a depletion of thymine deoxyribonucleotides. The effect of MTX on keratinocytes may provide a model for studying the relationship between deoxyribonucleotide metabolism and differentiation in normal cells. In addition, the ability of MTX to induce differentiation in keratinocytes suggests a mechanism to explain its therapeutic action in psoriasis.

Citing Articles

Treatment of nonmelanoma skin cancer with pro-differentiation agents and photodynamic therapy: Preclinical and clinical studies (Review).

Anand S, Hasan T, Maytin E Photochem Photobiol. 2024; 100(6):1541-1560.

PMID: 38310633 PMC: 11297983. DOI: 10.1111/php.13914.


Pyoderma gangrenosum.

Maverakis E, Marzano A, Le S, Callen J, Bruggen M, Guenova E Nat Rev Dis Primers. 2020; 6(1):81.

PMID: 33033263 DOI: 10.1038/s41572-020-0213-x.


Disparate Response to Methotrexate in Stem Versus Non-Stem Cells.

Beane O, Darling L, Fonseca V, Darling E Stem Cell Rev Rep. 2016; 12(3):340-51.

PMID: 26815725 PMC: 4880537. DOI: 10.1007/s12015-016-9645-9.


Frequent somatic reversion of KRT1 mutations in ichthyosis with confetti.

Choate K, Lu Y, Zhou J, Elias P, Zaidi S, Paller A J Clin Invest. 2015; 125(4):1703-7.

PMID: 25774499 PMC: 4396494. DOI: 10.1172/JCI64415.


Mechanism of differentiation-enhanced photodynamic therapy for cancer: upregulation of coproporphyrinogen oxidase by C/EBP transcription factors.

Anand S, Hasan T, Maytin E Mol Cancer Ther. 2013; 12(8):1638-50.

PMID: 23686770 PMC: 3743443. DOI: 10.1158/1535-7163.MCT-13-0047.


References
1.
Reiss M, Sartorelli A . Induction of tumor cell differentiation as a therapeutic approach: preclinical models for hematopoietic and solid neoplasms. Cancer Treat Rep. 1986; 70(1):201-18. View

2.
Watt F, Jordan P, ONeill C . Cell shape controls terminal differentiation of human epidermal keratinocytes. Proc Natl Acad Sci U S A. 1988; 85(15):5576-80. PMC: 281801. DOI: 10.1073/pnas.85.15.5576. View

3.
Weinstein G, McCullough J, Ross P . Cell kinetic basis for pathophysiology of psoriasis. J Invest Dermatol. 1985; 85(6):579-83. DOI: 10.1111/1523-1747.ep12283594. View

4.
Hohl D . Cornified cell envelope. Dermatologica. 1990; 180(4):201-11. DOI: 10.1159/000248031. View

5.
Albers K, Taichman L . Kinetics of withdrawal from the cell cycle in cultured human epidermal keratinocytes. J Invest Dermatol. 1984; 82(2):161-4. DOI: 10.1111/1523-1747.ep12259726. View